Professor Luke O’Neill on marvel molecules and being a scientist

Professor Luke O’Neill of the School of Biochemistry and Immunology talks to Trinity News about the exciting discovery of a molecule that could help treat a variety of inflammatory diseases.

Science HeaderNew research led by scientists at Trinity has uncovered a molecule that could lead to new treatment of inflammatory diseases including multiple sclerosis, Alzheimer’s, Parkinson’s, gout, asthma, diabetes and Muckle-Wells syndrome. This marvel molecule, called MCC950, is capable of blocking …